Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer entities : Exact sciences corporation save search
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
Published: 2024-04-04 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.01%
H: 0.24%
C: -4.41%
cancer treatment tumor sciences
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
oncoguard test cancer sciences
Liquid Biopsy Market Set to Reach US$ 10.08 Billion by 2030 with Pioneering Breakthroughs in Cancer Detection and Management
Published: 2024-02-16 (Crawled : 19:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
| Email alert
Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
management reach cancer set market
Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 | DelveInsight
Published: 2024-01-19 (Crawled : 22:00) - prnewswire.com
ANPCF | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
| Email alert
Add to watchlist
ANPCY | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
cancer global diagnostics growth market
Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
Published: 2023-12-07 (Crawled : 13:00) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.17%
H: 0.25%
C: -0.47%
cancer awards sciences grants
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.31%
H: 5.06%
C: 5.06%
breast symposium cancer sciences therapy
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
Published: 2023-11-30 (Crawled : 21:00) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.31%
H: 5.06%
C: 5.06%
breast symposium cancer sciences therapy
Gastric Cancer Diagnostic Market to Reach $3.8 Billion, Globally, by 2032 at 5.3% CAGR: Allied Market Research
Published: 2023-11-10 (Crawled : 15:30) - prnewswire.com
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -0.27%
H: 0.44%
C: -0.63%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.23%
H: 1.53%
C: 0.44%
diagnostic reach cancer research market
Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection
Published: 2023-10-22 (Crawled : 20:20) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.68%
H: 1.76%
C: 0.36%
cologuard test cancer
Redefining Colorectal Cancer (CRC) Landscape Report with DLI's Epidemiology Study, Drug Insights, Price Reimbursement, and Regulatory Consulting Services | Disease Landscape Insights
Published: 2023-10-09 (Crawled : 10:00) - prnewswire.com
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.99%
H: 0.56%
C: -0.61%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.29%
H: 3.53%
C: 3.1%
drug disease services report cancer
Global Precision Oncology Research Report 2023-2031: Liquid Biopsies, Genomic Breakthroughs, AI-Driven Insights - Revolutionizing Cancer Monitoring and Diagnosis
Published: 2023-08-30 (Crawled : 17:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 1.36%
H: 0.0%
C: 0.0%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -2.32%
H: 0.0%
C: 0.0%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.24%
H: 0.87%
C: -0.12%
report genomic cancer research global
Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials
Published: 2023-08-30 (Crawled : 14:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.24%
H: 0.87%
C: -0.12%
institute test cancer trials sciences
Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
Published: 2023-06-21 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 4.94%
H: 0.01%
C: -9.31%
cancer sciences
Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening
Published: 2023-06-20 (Crawled : 20:00) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 4.94%
H: 0.01%
C: -9.31%
cologuard test cancer
Global Colorectal Cancer Screening Market Report 2023: Sector is Expected to Reach $9.73 Billion by 2033 at a CAGR of 15.94%
Published: 2023-06-16 (Crawled : 19:00) - prnewswire.com
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
GH M | $16.08 -3.54% -3.67% 1.9M
|
Health Services
| Email alert
Add to watchlist
report expected reach cancer global market
Exact Sciences Presents New Long-Term Patient Outcomes in Multi-Cancer Early Detection and Breast Cancer Recurrence Testing at ASCO® 2023
Published: 2023-05-26 (Crawled : 11:00) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.26%
H: 2.94%
C: 1.72%
asco breast cancer sciences
EXACT SCIENCES AWARDS GRANTS TO 18 ORGANIZATIONS FOCUSED ON INCREASING COLORECTAL CANCER SCREENINGS
Published: 2023-05-17 (Crawled : 12:20) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.43%
H: 0.73%
C: -2.06%
cancer awards sciences grants
Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week® Annual Meeting
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -2.04%
H: 6.0%
C: 5.73%
week disease cancer sciences meeting
Exact Sciences Presents Advancements in Cancer Detection at American Association for Cancer Research® 2023 Annual Meeting
Published: 2023-04-12 (Crawled : 20:00) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.46%
H: 2.82%
C: 2.78%
research association cancer sciences meeting
Mdxhealth acquiert l’activité Oncotype DX® GPS pour le cancer de la prostate d’Exact Sciences et annonce ses résultats préliminaires pour le premier semestre 2022
Published: 2023-04-11 (Crawled : 00:00) - mdxhealth.com
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 0.6%
H: 0.77%
C: 0.2%
HOLX | $75.37 0.36% 0.36% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.56%
C: 0.42%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.33%
H: 2.57%
C: 1.66%
cancer sciences
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.